The results showed that LATS1/2 loss accelerated tumor growth more significantly in immunocompetent mice than in immunodeficient mice, highlighting the critical role of the host immune system in LATS1/2-mediated anti-tumor effect (Fig. 5G-I). This evidence concerns the gene LATS1 and neoplasm.